论文部分内容阅读
Anthracyclines,such as doxorubicin(DOX),epirubicin(EPI),and daunorubicin(DAU),are widely used in the treatment of hematologic and solid tumors [1].However,the therapeutic efficacy of anthracycline drugs may be limited due to their severe side-effects and drug resistance.